Serena Williams stepped out to a glitzy US Open party on Thursday night as the tennis icon was joined by other stars of the ...

C-store retailers answer this Rovertown ‘hot, or not’ question as well others on GLP-1, Gen Zers and more at Outlook Leadership ...

Serena Williams strutted in all-new photos just days after revealing she lost more than 30 pounds using a GLP-1 treatment ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

Fans rubbed their eyes in disbelief after Meghan Trainor shared a video of herself attempting a wild and risky challenge ...

In the wake of weight-loss drugs and the rising importance of health, the iconic cultural brand must double down on its roots ...

GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...

Serena Williams opens up about her weight loss struggles and the use of GLP-1 medications, highlighting issues of access and ...

So the, the question we're investigating in this study is whether the use of GLP-1 receptor agonists, which is *** medication ...

Serena Williams says “sometimes you need help” as she opens up about weight loss, breaking stigma, and finding balance after ...